November 2021 UTILITY OF BIOMARKERS OF REJECTION AND KIDNEY INJURY IN TAILORING LIVER TRANSPLANT IMMUNOSUPPRESSIONFeaturing: Josh Levitsky, MD, MS
Episode SummaryIn this episode of the Better Edge podcast, Josh Levitsky, MD, MS, professor of Medicine in the Divisions of Gastroenterology and Hepatology, Medical Education and Organ Transplantation at Northwestern Medicine, discusses the grant he received to conduct a clinical trial on the utility of biomarkers of rejection and kidney injury in tailoring liver transplant immunosuppression, and what findings could mean for the future of liver transplantation.
|
Josh Levitsky, MD, MS, professor of Medicine in the Divisions of Gastroenterology and Hepatology, Medical Education and Organ Transplantation at Northwestern Medicine
Refer a PatientNorthwestern Medicine welcomes the opportunity to collaborate with you in caring for your patients.
|